The Community Guide

- gsearch

Search Results

Narrow Results:

2024 4

Centers for Disease Control and Prevention (U.S.). 4

United States 4

Journal article 4

Statistics 4
Tables 4

1 - 4 of 4 Results

Refine Results

Refine Results:

Supplementary Figure 2. Comparison of Proportions of Omicron Lineage XBB.1.5 (a) and HV.1 (B) With 95% CIs, Nationally and by U.S. Department of Health and Human Services Regions 1–10, Estimated With COVID-19 Electronic Reporting and National Respiratory and Enteric Virus Surveillance System–Derived Weights Versus National Respiratory and Enteric Virus Surveillance System Alone — United States, May 14, 2023–November 11, 2023

CITE Title : Supplementary Figure 2. Comparison of Proportions of Omicron Lineage XBB.1.5 (a) and HV.1 (B) With 95% CIs, Nationally and by U.S. Department of Health and Human Services Regions 1–10, Estimated With COVID-19 Electronic Reporting and National Respiratory and Enteric Virus Surveillance System–Derived Weights Versus National Respiratory and Enteric Virus Surveillance System Alone — United States, May 14, 2023–November 11, 2023 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 10/24/2024 Pages in Document : 3 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 42 URL : https://stacks.cdc.gov/view/cdc/165773 Centers for Disease Control and Prevention (U.S.). (2024). Supplementary Figure 2. Comparison of Proportions of Omicron Lineage XBB.1.5 (a) and HV.1 (B) With 95% CIs, Nationally and by U.S. Department of Health and Human Services Regions 1–10, Estimated With COVID-19 Electronic Reporting and National Respiratory and Enteric Virus Surveillance System–Derived Weights Versus National Respiratory and Enteric Virus Surveillance System Alone — United States, May 14, 2023–November 11, 2023. 73(42). Centers for Disease Control and Prevention (U.S.). "Supplementary Figure 2. Comparison of Proportions of Omicron Lineage XBB.1.5 (a) and HV.1 (B) With 95% CIs, Nationally and by U.S. Department of Health and Human Services Regions 1–10, Estimated With COVID-19 Electronic Reporting and National Respiratory and Enteric Virus Surveillance System–Derived Weights Versus National Respiratory and Enteric Virus Surveillance System Alone — United States, May 14, 2023–November 11, 2023" 73, no. 42 (2024) Centers for Disease Control and Prevention (U.S.). "Supplementary Figure 2. Comparison of Proportions of Omicron Lineage XBB.1.5 (a) and HV.1 (B) With 95% CIs, Nationally and by U.S. Department of Health and Human Services Regions 1–10, Estimated With COVID-19 Electronic Reporting and National Respiratory and Enteric Virus Surveillance System–Derived Weights Versus National Respiratory and Enteric Virus Surveillance System Alone — United States, May 14, 2023–November 11, 2023" vol. 73, no. 42, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

10/24/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary Figure. Morbidity and Mortality Weekly Report, Vol. 73, No. 42, October 24, 2024
Supplementary Figure 3. Estimated Variant Proportions With 95% Confidence Intervals During the First 14 Weeks of Each Variant’s Emergence (From the Time of Exceeding 1% of National Circulating Viruses) for SARS-CoV-2 Variants Reaching Predominance (>50% Prevalence) — United States, June 2021–September 2024

CITE Title : Supplementary Figure 3. Estimated Variant Proportions With 95% Confidence Intervals During the First 14 Weeks of Each Variant’s Emergence (From the Time of Exceeding 1% of National Circulating Viruses) for SARS-CoV-2 Variants Reaching Predominance (>50% Prevalence) — United States, June 2021–September 2024 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 10/24/2024 Pages in Document : 1 pdf page Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 42 URL : https://stacks.cdc.gov/view/cdc/165774 Centers for Disease Control and Prevention (U.S.). (2024). Supplementary Figure 3. Estimated Variant Proportions With 95% Confidence Intervals During the First 14 Weeks of Each Variant’s Emergence (From the Time of Exceeding 1% of National Circulating Viruses) for SARS-CoV-2 Variants Reaching Predominance (>50% Prevalence) — United States, June 2021–September 2024. 73(42). Centers for Disease Control and Prevention (U.S.). "Supplementary Figure 3. Estimated Variant Proportions With 95% Confidence Intervals During the First 14 Weeks of Each Variant’s Emergence (From the Time of Exceeding 1% of National Circulating Viruses) for SARS-CoV-2 Variants Reaching Predominance (>50% Prevalence) — United States, June 2021–September 2024" 73, no. 42 (2024) Centers for Disease Control and Prevention (U.S.). "Supplementary Figure 3. Estimated Variant Proportions With 95% Confidence Intervals During the First 14 Weeks of Each Variant’s Emergence (From the Time of Exceeding 1% of National Circulating Viruses) for SARS-CoV-2 Variants Reaching Predominance (>50% Prevalence) — United States, June 2021–September 2024" vol. 73, no. 42, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

10/24/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary Figure. Morbidity and Mortality Weekly Report, Vol. 73, No. 42, October 24, 2024
Supplementary Figure 1. Weekly Counts of Sequences Generated By or Submitted to CDC From the National SARS-CoV-2 Strain Surveillance Program, Contract Commercial Laboratories, and Public Sequence Data Repositories — United States, June 1, 2022–September 14, 2024

CITE Title : Supplementary Figure 1. Weekly Counts of Sequences Generated By or Submitted to CDC From the National SARS-CoV-2 Strain Surveillance Program, Contract Commercial Laboratories, and Public Sequence Data Repositories — United States, June 1, 2022–September 14, 2024 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 10/24/2024 Pages in Document : 1 pdf page Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 42 URL : https://stacks.cdc.gov/view/cdc/165772 Centers for Disease Control and Prevention (U.S.). (2024). Supplementary Figure 1. Weekly Counts of Sequences Generated By or Submitted to CDC From the National SARS-CoV-2 Strain Surveillance Program, Contract Commercial Laboratories, and Public Sequence Data Repositories — United States, June 1, 2022–September 14, 2024. 73(42). Centers for Disease Control and Prevention (U.S.). "Supplementary Figure 1. Weekly Counts of Sequences Generated By or Submitted to CDC From the National SARS-CoV-2 Strain Surveillance Program, Contract Commercial Laboratories, and Public Sequence Data Repositories — United States, June 1, 2022–September 14, 2024" 73, no. 42 (2024) Centers for Disease Control and Prevention (U.S.). "Supplementary Figure 1. Weekly Counts of Sequences Generated By or Submitted to CDC From the National SARS-CoV-2 Strain Surveillance Program, Contract Commercial Laboratories, and Public Sequence Data Repositories — United States, June 1, 2022–September 14, 2024" vol. 73, no. 42, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

10/24/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary Figure. Morbidity and Mortality Weekly Report, Vol. 73, No. 42, October 24, 2024
Supplementary Table. Voyage Timeframes and Regions of Travel for Patients With Confirmed and Probable Legionnaires Disease — Cruise Ships A and B, 2022–2024

CITE Title : Supplementary Table. Voyage Timeframes and Regions of Travel for Patients With Confirmed and Probable Legionnaires Disease — Cruise Ships A and B, 2022–2024 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 10/24/2024 Pages in Document : 1 pdf page Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 42 URL : https://stacks.cdc.gov/view/cdc/165771 Centers for Disease Control and Prevention (U.S.). (2024). Supplementary Table. Voyage Timeframes and Regions of Travel for Patients With Confirmed and Probable Legionnaires Disease — Cruise Ships A and B, 2022–2024. 73(42). Centers for Disease Control and Prevention (U.S.). "Supplementary Table. Voyage Timeframes and Regions of Travel for Patients With Confirmed and Probable Legionnaires Disease — Cruise Ships A and B, 2022–2024" 73, no. 42 (2024) Centers for Disease Control and Prevention (U.S.). "Supplementary Table. Voyage Timeframes and Regions of Travel for Patients With Confirmed and Probable Legionnaires Disease — Cruise Ships A and B, 2022–2024" vol. 73, no. 42, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

10/24/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

No Description